Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection.

UNLABELLED:A rapid expansion of HFMD with enterovirus 71 infection outbreaks has occurred and caused deaths in recent years in China, but no vaccine or antiviral drug is currently available for EV71 infection. This study aims to provide treatment programs for HFMD patients. We conducted a randomized...

Full description

Bibliographic Details
Main Authors: Xueyong Huang, Xi Zhang, Fang Wang, Haiyan Wei, Hong Ma, Meili Sui, Jie Lu, Huaili Wang, J Stephen Dumler, Guangyao Sheng, Bianli Xu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4755579?pdf=render
_version_ 1811207018097147904
author Xueyong Huang
Xi Zhang
Fang Wang
Haiyan Wei
Hong Ma
Meili Sui
Jie Lu
Huaili Wang
J Stephen Dumler
Guangyao Sheng
Bianli Xu
author_facet Xueyong Huang
Xi Zhang
Fang Wang
Haiyan Wei
Hong Ma
Meili Sui
Jie Lu
Huaili Wang
J Stephen Dumler
Guangyao Sheng
Bianli Xu
author_sort Xueyong Huang
collection DOAJ
description UNLABELLED:A rapid expansion of HFMD with enterovirus 71 infection outbreaks has occurred and caused deaths in recent years in China, but no vaccine or antiviral drug is currently available for EV71 infection. This study aims to provide treatment programs for HFMD patients. We conducted a randomized, double-blind, controlled trial and evaluated clinical efficacy of therapy with rHuIFN-α1b in HFMD patients with EV71 infection. There were statistical differences in outcomes including the fever clearance time, healing time of typical skin or oral mucosa lesions, and EV71 viral load of the HFMD patients among ultrasonic aerosol inhalation group, intramuscular injection group and control group. rHuIFN-α1b therapy reduced the fever clearance time, healing time of typical skin or oral mucosa lesions, and EV71 viral load in children with HFMD. TRIAL REGISTRATION:Chinese Clinical Trial Registry ChiCTR-TRC-14005153.
first_indexed 2024-04-12T03:57:51Z
format Article
id doaj.art-065dd3697d38489ab62e7608a8aa7309
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T03:57:51Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-065dd3697d38489ab62e7608a8aa73092022-12-22T03:48:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014890710.1371/journal.pone.0148907Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection.Xueyong HuangXi ZhangFang WangHaiyan WeiHong MaMeili SuiJie LuHuaili WangJ Stephen DumlerGuangyao ShengBianli XuUNLABELLED:A rapid expansion of HFMD with enterovirus 71 infection outbreaks has occurred and caused deaths in recent years in China, but no vaccine or antiviral drug is currently available for EV71 infection. This study aims to provide treatment programs for HFMD patients. We conducted a randomized, double-blind, controlled trial and evaluated clinical efficacy of therapy with rHuIFN-α1b in HFMD patients with EV71 infection. There were statistical differences in outcomes including the fever clearance time, healing time of typical skin or oral mucosa lesions, and EV71 viral load of the HFMD patients among ultrasonic aerosol inhalation group, intramuscular injection group and control group. rHuIFN-α1b therapy reduced the fever clearance time, healing time of typical skin or oral mucosa lesions, and EV71 viral load in children with HFMD. TRIAL REGISTRATION:Chinese Clinical Trial Registry ChiCTR-TRC-14005153.http://europepmc.org/articles/PMC4755579?pdf=render
spellingShingle Xueyong Huang
Xi Zhang
Fang Wang
Haiyan Wei
Hong Ma
Meili Sui
Jie Lu
Huaili Wang
J Stephen Dumler
Guangyao Sheng
Bianli Xu
Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection.
PLoS ONE
title Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection.
title_full Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection.
title_fullStr Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection.
title_full_unstemmed Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection.
title_short Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection.
title_sort clinical efficacy of therapy with recombinant human interferon α1b in hand foot and mouth disease with enterovirus 71 infection
url http://europepmc.org/articles/PMC4755579?pdf=render
work_keys_str_mv AT xueyonghuang clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection
AT xizhang clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection
AT fangwang clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection
AT haiyanwei clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection
AT hongma clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection
AT meilisui clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection
AT jielu clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection
AT huailiwang clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection
AT jstephendumler clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection
AT guangyaosheng clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection
AT bianlixu clinicalefficacyoftherapywithrecombinanthumaninterferona1binhandfootandmouthdiseasewithenterovirus71infection